Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-13 4:54 pm Unchanged | 2024-05-13 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-03-25 4:43 pm Unchanged | 2024-03-25 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-08 5:44 pm Unchanged | 2024-02-08 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-08 5:41 pm Unchanged | 2024-02-08 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-02-08 5:35 pm Unchanged | 2024-02-08 | 13G | Century Therapeutics, Inc. IPSC | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-17 4:38 pm Unchanged | 2023-11-17 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-09 5:28 pm Unchanged | 2023-11-09 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-09 5:27 pm Unchanged | 2023-11-09 | 13D | Passage Bio, Inc. PASG | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-09 5:26 pm Unchanged | 2023-11-09 | 13D | Monte Rosa Therapeutics, Inc. GLUE | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-11-09 5:24 pm Unchanged | 2023-11-09 | 13D | Black Diamond Therapeutics, Inc. BDTX | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-09 4:19 pm Unchanged | 2023-02-09 | 13G | Century Therapeutics, Inc. IPSC | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-01-13 4:09 pm Unchanged | 2023-01-13 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-05-09 5:26 pm Unchanged | 2022-05-09 | 13D | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 8:39 pm Unchanged | 2022-02-10 | 13G | Century Therapeutics, Inc. IPSC | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-02-10 7:41 pm Unchanged | 2022-02-10 | 13G | Tempest Therapeutics, Inc. TPST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-13 4:34 pm Unchanged | 2022-01-13 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-10-27 4:32 pm Unchanged | 2021-10-27 | 13D | Oyster Point Pharma, Inc. OYST | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-09 4:43 pm Unchanged | 2021-07-09 | 13D | LENZ Therapeutics, Inc. LENZ | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-07-08 4:31 pm Unchanged | 2021-07-08 | 13D | Monte Rosa Therapeutics, Inc. GLUE | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2021-06-21 4:44 pm Unchanged | 2021-06-21 | 13D | Aligos Therapeutics, Inc. ALGS | Versant Venture Capital VI, L.P. | 0 0.000% | 0 (Unchanged) | Filing |